HOB Net Receivables vs Non Current Liabilities Total Analysis

688656 Stock

104.14 1.64 1.60%

HOB Biotech financial indicator trend analysis is much more than just examining HOB Biotech Group latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HOB Biotech Group is a good investment. Please check the relationship between HOB Biotech Net Receivables and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HOB Biotech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Net Receivables vs Non Current Liabilities Total

Net Receivables vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HOB Biotech Group Net Receivables account and Non Current Liabilities Total. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between HOB Biotech's Net Receivables and Non Current Liabilities Total is -0.45. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of HOB Biotech Group, assuming nothing else is changed. The correlation between historical values of HOB Biotech's Net Receivables and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of HOB Biotech Group are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Net Receivables i.e., HOB Biotech's Net Receivables and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

-0.45

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Receivables

Non Current Liabilities Total

Most indicators from HOB Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HOB Biotech Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in HOB Biotech Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 110.9 M, whereas Tax Provision is forecasted to decline to about 7.2 M.

	2021	2022	2023	2024 (projected)
Interest Expense	1.2M	1.9M	2.5M	1.9M
Depreciation And Amortization	27.6M	33.3M	38.2M	40.2M

Interest Expense Depreciation And Amortization

HOB Biotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Net Receivables	Net Invested Capital
Total Assets		0.64	0.18	0.84	1.0	0.85	-0.72	0.9	0.79	0.8	0.85	-0.05	0.93	0.99	-0.49	0.92	-0.56	0.93	0.81	0.94	0.64	0.83	0.85	0.89	0.92	0.98
Short Long Term Debt Total	0.64		-0.14	0.75	0.62	0.69	-0.02	0.61	0.74	0.15	0.69	0.03	0.43	0.64	-0.34	0.74	-0.68	0.58	0.74	0.39	0.94	0.64	0.49	0.61	0.59	0.62
Other Current Liab	0.18	-0.14		0.37	0.15	-0.15	-0.39	-0.08	0.08	0.35	-0.16	-0.49	0.13	0.07	0.26	0.18	0.07	-0.03	0.4	0.37	-0.1	0.41	0.38	0.08	-0.06	0.01
Total Current Liabilities	0.84	0.75	0.37		0.8	0.79	-0.41	0.73	0.79	0.51	0.79	-0.21	0.72	0.81	-0.48	0.89	-0.51	0.77	0.99	0.72	0.78	0.81	0.79	0.65	0.67	0.78
Total Stockholder Equity	1.0	0.62	0.15	0.8		0.84	-0.74	0.9	0.77	0.82	0.84	-0.02	0.93	0.99	-0.49	0.9	-0.55	0.92	0.77	0.94	0.61	0.81	0.84	0.9	0.92	0.98
Property Plant And Equipment Net	0.85	0.69	-0.15	0.79	0.84		-0.44	0.96	0.74	0.54	1.0	-0.05	0.85	0.91	-0.63	0.87	-0.58	0.96	0.78	0.72	0.65	0.69	0.74	0.77	0.89	0.91
Net Debt	-0.72	-0.02	-0.39	-0.41	-0.74	-0.44		-0.63	-0.27	-0.99	-0.45	0.06	-0.84	-0.71	0.37	-0.53	0.36	-0.67	-0.38	-0.9	-0.07	-0.63	-0.64	-0.63	-0.68	-0.7
Retained Earnings	0.9	0.61	-0.08	0.73	0.9	0.96	-0.63		0.69	0.71	0.96	-0.08	0.93	0.94	-0.53	0.87	-0.67	0.98	0.72	0.83	0.54	0.79	0.78	0.89	0.97	0.94
Accounts Payable	0.79	0.74	0.08	0.79	0.77	0.74	-0.27	0.69		0.36	0.74	0.18	0.6	0.79	-0.28	0.71	-0.45	0.71	0.8	0.63	0.73	0.6	0.55	0.67	0.61	0.78
Cash	0.8	0.15	0.35	0.51	0.82	0.54	-0.99	0.71	0.36		0.54	-0.06	0.9	0.79	-0.42	0.62	-0.44	0.75	0.48	0.94	0.19	0.71	0.7	0.7	0.76	0.78
Non Current Assets Total	0.85	0.69	-0.16	0.79	0.84	1.0	-0.45	0.96	0.74	0.54		-0.03	0.86	0.91	-0.64	0.86	-0.59	0.96	0.77	0.72	0.66	0.69	0.73	0.77	0.89	0.91
Non Currrent Assets Other	-0.05	0.03	-0.49	-0.21	-0.02	-0.05	0.06	-0.08	0.18	-0.06	-0.03		-0.05	0.04	-0.33	-0.34	-0.01	0.0	-0.29	-0.1	0.19	-0.39	-0.51	-0.23	-0.14	0.07
Cash And Short Term Investments	0.93	0.43	0.13	0.72	0.93	0.85	-0.84	0.93	0.6	0.9	0.86	-0.05		0.95	-0.62	0.82	-0.57	0.96	0.69	0.95	0.45	0.78	0.8	0.81	0.92	0.95
Common Stock Shares Outstanding	0.99	0.64	0.07	0.81	0.99	0.91	-0.71	0.94	0.79	0.79	0.91	0.04	0.95		-0.58	0.89	-0.59	0.97	0.78	0.92	0.64	0.79	0.8	0.86	0.93	1.0
Non Current Liabilities Total	-0.49	-0.34	0.26	-0.48	-0.49	-0.63	0.37	-0.53	-0.28	-0.42	-0.64	-0.33	-0.62	-0.58		-0.42	0.24	-0.65	-0.37	-0.42	-0.55	-0.21	-0.34	-0.17	-0.45	-0.59
Inventory	0.92	0.74	0.18	0.89	0.9	0.87	-0.53	0.87	0.71	0.62	0.86	-0.34	0.82	0.89	-0.42		-0.57	0.86	0.89	0.8	0.68	0.87	0.92	0.88	0.89	0.87
Other Current Assets	-0.56	-0.68	0.07	-0.51	-0.55	-0.58	0.36	-0.67	-0.45	-0.44	-0.59	-0.01	-0.57	-0.59	0.24	-0.57		-0.59	-0.53	-0.51	-0.57	-0.77	-0.38	-0.66	-0.66	-0.57
Other Stockholder Equity	0.93	0.58	-0.03	0.77	0.92	0.96	-0.67	0.98	0.71	0.75	0.96	0.0	0.96	0.97	-0.65	0.86	-0.59		0.74	0.86	0.57	0.74	0.78	0.82	0.94	0.97
Total Liab	0.81	0.74	0.4	0.99	0.77	0.78	-0.38	0.72	0.8	0.48	0.77	-0.29	0.69	0.78	-0.37	0.89	-0.53	0.74		0.71	0.73	0.84	0.8	0.67	0.66	0.74
Total Current Assets	0.94	0.39	0.37	0.72	0.94	0.72	-0.9	0.83	0.63	0.94	0.72	-0.1	0.95	0.92	-0.42	0.8	-0.51	0.86	0.71		0.4	0.83	0.83	0.83	0.85	0.91
Short Term Debt	0.64	0.94	-0.1	0.78	0.61	0.65	-0.07	0.54	0.73	0.19	0.66	0.19	0.45	0.64	-0.55	0.68	-0.57	0.57	0.73	0.4		0.54	0.45	0.46	0.5	0.63
Intangible Assets	0.83	0.64	0.41	0.81	0.81	0.69	-0.63	0.79	0.6	0.71	0.69	-0.39	0.78	0.79	-0.21	0.87	-0.77	0.74	0.84	0.83	0.54		0.84	0.85	0.81	0.75
Common Stock	0.85	0.49	0.38	0.79	0.84	0.74	-0.64	0.78	0.55	0.7	0.73	-0.51	0.8	0.8	-0.34	0.92	-0.38	0.78	0.8	0.83	0.45	0.84		0.8	0.8	0.78
Long Term Debt	0.89	0.61	0.08	0.65	0.9	0.77	-0.63	0.89	0.67	0.7	0.77	-0.23	0.81	0.86	-0.17	0.88	-0.66	0.82	0.67	0.83	0.46	0.85	0.8		0.94	0.86
Net Receivables	0.92	0.59	-0.06	0.67	0.92	0.89	-0.68	0.97	0.61	0.76	0.89	-0.14	0.92	0.93	-0.45	0.89	-0.66	0.94	0.66	0.85	0.5	0.81	0.8	0.94		0.93
Net Invested Capital	0.98	0.62	0.01	0.78	0.98	0.91	-0.7	0.94	0.78	0.78	0.91	0.07	0.95	1.0	-0.59	0.87	-0.57	0.97	0.74	0.91	0.63	0.75	0.78	0.86	0.93

Click cells to compare fundamentals

HOB Biotech Account Relationship Matchups

HOB Biotech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	283.2M	296.4M	863.9M	944.6M	949.3M	526.8M
Short Long Term Debt Total	50.1M	44.0M	30.9M	65.4M	75.2M	44.6M
Other Current Liab	72.0M	35.7M	49.5M	48.7M	3.1M	3.0M
Total Current Liabilities	122.9M	63.2M	86.2M	152.7M	135.8M	102.6M
Total Stockholder Equity	149.6M	206.4M	770.0M	779.6M	810.7M	410.5M
Property Plant And Equipment Net	82.1M	120.0M	260.0M	485.3M	578.7M	607.6M
Net Debt	(40.7M)	(14.8M)	(419.0M)	(88.4M)	(79.5M)	(83.5M)
Retained Earnings	23.1M	72.9M	131.3M	133.9M	162.1M	170.2M
Accounts Payable	5.9M	7.5M	11.1M	48.3M	23.9M	15.2M
Cash	90.8M	58.8M	449.9M	153.8M	163.5M	138.9M
Non Current Assets Total	106.7M	137.8M	293.9M	521.6M	621.0M	652.1M
Non Currrent Assets Other	10.3M	5.5M	20.1M	21.9M	16.4M	16.5M
Cash And Short Term Investments	90.8M	58.8M	454.9M	289.0M	332.4M	349.0M
Common Stock Shares Outstanding	47.3M	47.2M	61.6M	63.1M	63.1M	57.6M
Liabilities And Stockholders Equity	283.2M	296.4M	863.9M	944.6M	1.1B	1.1B
Non Current Liabilities Total	10.6M	26.8M	7.8M	12.3M	2.8M	2.6M
Inventory	59.6M	61.9M	68.2M	87.8M	111.2M	69.7M
Other Current Assets	2.2M	1.3M	3.0M	3.9M	959.4K	911.4K
Other Stockholder Equity	79.3M	86.1M	575.6M	582.6M	670.0M	703.5M
Total Liab	133.5M	90.0M	93.9M	165.0M	138.5M	116.4M
Total Current Assets	176.5M	158.7M	570.0M	423.0M	328.2M	263.7M
Short Term Debt	45.0M	20.0M	25.5M	55.7M	64.0M	34.4M
Intangible Assets	11.7M	11.3M	12.2M	12.6M	11.9M	8.4M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in HOB Stock

Balance Sheet is a snapshot of the financial position of HOB Biotech Group at a specified time, usually calculated after every quarter, six months, or one year. HOB Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of HOB Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which HOB currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HOB Net Receivables vs Non Current Liabilities Total Analysis

Net Receivables vs Non Current Liabilities Total

Net Receivables vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Net Receivables

Non Current Liabilities Total

HOB Biotech fundamental ratios Correlations

HOB Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HOB Biotech fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in HOB Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Net Invested Capital	+ 1.0	Common Stock Shares Outstanding
Common Stock Shares Outstanding	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Current Liabilities
Common Stock Shares Outstanding	+ 0.99	Total Stockholder Equity

Cash	- 0.99	Net Debt
Total Current Assets	- 0.9	Net Debt
Cash And Short Term Investments	- 0.84	Net Debt
Intangible Assets	- 0.77	Other Current Assets
Net Debt	- 0.74	Total Stockholder Equity
Net Debt	- 0.72	Total Assets